These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 21605234)

  • 21. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
    Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
    Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature.
    Lowenstein SE; Garrett G; Toland AE; Jambusaria-Pahlajani A; Asgari MM; Green A; Engels EA; Arron ST;
    Br J Dermatol; 2017 Nov; 177(5):1202-1207. PubMed ID: 28952162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent non-melanoma skin cancer: remission of field cancerization after conversion from calcineurin inhibitor- to proliferation signal inhibitor-based immunosuppression in a cardiac transplant recipient.
    Signorell J; Hunziker T; Martinelli M; Koestner SC; Mohacsi PJ
    Transplant Proc; 2010 Nov; 42(9):3871-5. PubMed ID: 21094874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
    Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
    J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview on non-melanoma skin cancers in solid organ transplant recipients.
    Forchetti G; Suppa M; Del Marmol V
    G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
    Gluck M; Hodak E; Davidovici B
    Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year Results.
    Dantal J; Morelon E; Rostaing L; Goffin E; Brocard A; Tromme I; Broeders N; Del Marmol V; Chatelet V; Dompmartin A; Kessler M; Serra A; Hofbauer GFL; Kamar N; Pouteil-Noble C; Kanitakis J; Roux A; Decullier E; Euvrard S;
    J Clin Oncol; 2018 Sep; 36(25):2612-2620. PubMed ID: 30016177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirolimus: a potential chemopreventive agent.
    Fernandez A; Hu S; Kirsner RS
    J Invest Dermatol; 2008 Oct; 128(10):2352. PubMed ID: 18787541
    [No Abstract]   [Full Text] [Related]  

  • 30. For organ transplant recipients, cancer threatens long-term survival.
    Ross K
    J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
    [No Abstract]   [Full Text] [Related]  

  • 31. Conversion from calcineurin inhibitors to sirolimus reduces vascularization and thickness of post-transplant cutaneous squamous cell carcinomas.
    Rival-Tringali AL; Euvrard S; Decullier E; Claudy A; Faure M; Kanitakis J
    Anticancer Res; 2009 Jun; 29(6):1927-32. PubMed ID: 19528449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
    Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
    Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous cell carcinoma in organ transplant recipients: approach to management.
    Carucci JA
    Skin Therapy Lett; 2004 Apr; 9(4):5-7. PubMed ID: 15146264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keratinocyte cancer and its precursors in organ transplant patients.
    Jenni D; Hofbauer GF
    Curr Probl Dermatol; 2015; 46():49-57. PubMed ID: 25561206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Skin cancer and other skin disorders in patients following solid organ transplantation].
    de Graaf YG; de Fijter JW; Posma AN; Feltkamp MC; Claas FH; Bouwes Bavinck JN
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):511-7. PubMed ID: 15782685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin cancers following pediatric organ transplantation.
    Euvrard S; Kanitakis J; Cochat P; Claudy A
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):616-21. PubMed ID: 15061845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy of sirolimus and acitretin in solid organ transplant recipients: a new cutaneous adverse event.
    Skillen LA; Corry A
    Clin Exp Dermatol; 2019 Jan; 44(1):62-63. PubMed ID: 30430627
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients.
    Carucci JA; Martinez JC; Zeitouni NC; Christenson L; Coldiron B; Zweibel S; Otley CC
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):651-5. PubMed ID: 15061850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cutaneous complications after organ transplantation].
    Gjersvik PJ
    Tidsskr Nor Laegeforen; 1999 Oct; 119(25):3789-92. PubMed ID: 10574059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.